Dr. Reddy’s enters hormone replacement therapy market
after close1 source ↓written by the desknot a recommendation
Dr. Reddy’s Laboratories has acquired trademarks for Progynova and Cyclo-Progynova from Mercury Pharma Group, enhancing its gynaecology portfolio. Progynova, leading in the Estradiol market, generated sales of ₹100 cr in 2025. This move marks a strategic entry into the hormone replacement therapy (HRT) segment, potentially boosting market presence.
Not investment advice. For informational purposes only.